Clindamycin and Benzoyl Peroxide Topical
Clindamycin and benzoyl peroxide is a two-ingredient topical combination used to treat acne vulgaris.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 33 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Clindamycin and Benzoyl Peroxide Topical: Patient Information Guide
A plain-language walkthrough of Clindamycin and Benzoyl Peroxide Topical — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Clindamycin and benzoyl peroxide topical is a combination gel used to treat acne directly on the skin.
- Clindamycin Phosphate and Benzoyl Peroxide Gel (1.2%/3.75%) is approved for the topical treatment of acne vulgaris in patients 12 years of age and older
⚙️How it works▾
This gel combines two ingredients that fight acne in different ways. Clindamycin is an antibacterial that attaches to bacteria and stops them from making proteins — essentially shutting down their ability to grow and survive. Benzoyl peroxide is an oxidizing agent that kills bacteria on the skin and has keratolytic effects, meaning it helps break up the buildup of dead skin cells that can block pores. Both ingredients have shown activity against Propionibacterium acnes (now also called Cutibacterium acnes), a bacterium closely linked to acne development.
It's worth knowing that P. acnes can develop resistance to clindamycin over time, and resistance to clindamycin is often linked to resistance to erythromycin as well. This is one reason the combination formula is used — to help reduce the chance of resistance developing.
💊How it's taken▾
Apply this gel to the face once daily, using only a pea-sized amount. Before applying, wash your face gently with a mild soap, rinse with warm water, and pat dry.
- For skin use only — keep away from eyes, mouth, mucous membranes, and broken skin
- Use beyond 12 weeks has not been evaluated; follow your prescriber's guidance on duration
- If you miss a dose, apply it as soon as you remember — but if it's almost time for your next application, skip the missed one and resume your usual schedule
🤒Side effects — in detail▾
Most side effects with this gel are mild and happen on the skin where you apply it.
- Burning sensation
- Contact dermatitis (skin irritation or inflammation at the application site)
- Itching (pruritus)
- Rash
- Redness (erythema)
- Scaling or flaking skin
- Stinging
Local skin reactions like redness, scaling, and burning tend to peak around week 4 and improve by week 12. However, if you develop severe or persistent diarrhea, bloody stools, or severe stomach cramps, stop using the gel and contact your doctor right away — this could signal a serious condition called colitis.
⚠️Warnings & precautions▾
- Colitis risk: Clindamycin can be absorbed through the skin even when applied topically. Serious colon inflammation — including pseudomembranous colitis (a dangerous infection caused by Clostridioides difficile bacteria) — has been reported. Severe colitis can be life-threatening. Stop using the gel immediately and call your doctor if you develop significant diarrhea, bloody stools, or severe abdominal cramps. Do not take anti-diarrheal medicines like loperamide without medical guidance, as they may worsen the condition.
- Sun sensitivity: Minimize sun exposure, tanning beds, and sun lamps after applying this medication.
- Skin irritation from combining products: Using other acne treatments at the same time — especially peeling, scrubbing, or drying agents — can increase skin irritation. Reduce application frequency or take a break if your skin becomes very irritated. Discontinue if irritation does not resolve.
🔀What it interacts with▾
There are a few important interactions to know about with this gel.
- Erythromycin (topical or oral): Do not use together — lab studies show these two antibacterials can work against each other, which could reduce effectiveness
- Neuromuscular blocking agents (medicines used during anesthesia to relax muscles): Clindamycin may strengthen their muscle-relaxing effects; use with caution and make sure your medical team knows you use this gel before any procedure
- Other topical acne products (especially peeling, desquamating, or abrasive agents): Combining them can cause cumulative skin irritation; use with caution
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you have ever had a serious allergic reaction — including anaphylaxis (life-threatening allergic reaction) — to clindamycin, benzoyl peroxide, lincomycin, or any ingredient in the product
- Do not use if you have a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis
- Tell your doctor if you are pregnant — there are no reliable safety studies of this specific topical gel in pregnant women; discuss the risks and benefits with your provider
- If you are breastfeeding and apply this product to the chest, take care to prevent your infant from accidentally ingesting it; clindamycin has been detected in breast milk following oral and injectable use
- Not evaluated in children under 12 years old — safety and effectiveness in this age group are unknown
- Not enough data exist to determine if adults 65 and older respond differently than younger patients
🔬Pharmacokinetics — how your body processes it▾
Some clindamycin from this gel is absorbed through the skin into the bloodstream, though the amount is very small. In a study of adults with moderate to severe acne using a similar gel once daily for 30 days, measurable clindamycin blood levels were detected in most participants, but levels were undetectable 24 hours after each dose — meaning it does not meaningfully build up in the body between daily applications.
Benzoyl peroxide is also absorbed through the skin, where it is converted to benzoic acid. The full extent of systemic absorption for the specific 1.2%/3.75% gel formulation has not been formally evaluated.
📦How to store it▾
Store in a refrigerator, 2°C to 8°C (36°F to 46°F). Store at 20° to 25°C (68° to 77°F) . Protect from freezing.
📄 Written from Clindamycin and Benzoyl Peroxide Topical’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Clindamycin and Benzoyl Peroxide Topical — the kind of thing our pharmacy team would talk through with you at the counter.
What is this gel actually supposed to do for my acne? ▾
How do I apply it correctly? ▾
My skin is getting red and irritated — is that normal? ▾
I've heard something about diarrhea being a concern — should I be worried? ▾
Can I use other acne products or treatments at the same time? ▾
Is it safe to use if I'm pregnant or breastfeeding? ▾
Is Clindamycin and Benzoyl Peroxide Topical available over the counter? ▾
When was Clindamycin and Benzoyl Peroxide Topical first available? ▾
Who makes Clindamycin and Benzoyl Peroxide Topical? ▾
💬 Answers drafted from Clindamycin and Benzoyl Peroxide Topical’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Clindamycin and Benzoyl Peroxide Topical comes
Clindamycin and Benzoyl Peroxide Topical is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Topical cream, ointment or gel
How this form is used
- Clindamycin Phosphate and Benzoyl Peroxide Gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
- Clindamycin Phosphate and Benzoyl Peroxide Gel: before applying, gently wash your face with a mild soap, rinse with warm water, and pat skin dry
- Clindamycin Phosphate and Benzoyl Peroxide Gel: apply a pea-sized amount to the face once daily
- Clindamycin Phosphate and Benzoyl Peroxide Gel: avoid contact with the eyes, mouth, mucous membranes, and broken skin
- Clindamycin Phosphate and Benzoyl Peroxide Gel: for skin use only — not for oral, eye, or vaginal use
Show 1 more strength Show fewer strengths
📊 Clindamycin and Benzoyl Peroxide Topical across the U.S. market
How Clindamycin and Benzoyl Peroxide Topical appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Kit (29) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Clindamycin and Benzoyl Peroxide Topical is used
A general measure of how commonly Clindamycin and Benzoyl Peroxide Topical is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Clindamycin and Benzoyl Peroxide Topical is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Clindamycin and Benzoyl Peroxide Topical prescribed? Of the 1,594 medications we measure, Clindamycin and Benzoyl Peroxide Topical ranks #324 by Medicaid prescriptions — more than 80% of them.
Utilization by Clindamycin and Benzoyl Peroxide Topical product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
Other Clindamycin and Benzoyl Peroxide Topical products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 33 of 56 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Clindamycin and Benzoyl Peroxide Topical, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 33 of 56 listed Clindamycin and Benzoyl Peroxide Topical NDCs with Medicaid activity.
🔍 Compare Clindamycin and Benzoyl Peroxide Topical products
A representative set of FDA-listed product records for Clindamycin and Benzoyl Peroxide Topical — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Topical cream, ointment or gel | ||||
| BENZOYL PEROXIDE 25 mg/g; CLINDAMYCIN PHOSPHATE 10 mg/g | Topical | Actavis Pharma, Inc. | ANDA | View NDC → |
| 25; 10 mg/g; mg/g | Topical | Actavis Pharma, Inc. | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 25 mg/g | Topical | Bausch Health US, LLC | NDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 37.5 mg/g | Topical | Bausch Health US, LLC | NDA | View NDC → |
| 37.5; 10 mg/g; mg/g | Topical | Bausch Health US, LLC | NDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Bausch Health US LLC × 2 listings | NDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 37.5 mg/g | Topical | Bryant Ranch Prepack | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| BENZOYL PEROXIDE 25 mg/g; CLINDAMYCIN PHOSPHATE 10 mg/g | Topical | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 25; 10 mg/g; mg/g | Topical | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 50; 12 mg/g; mg/g | Topical | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 25 mg/g | Topical | Encube Ethicals, Inc. × 2 listings | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Encube Ethicals, Inc. | ANDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Encube Ethicals Private Limited | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Glenmark Pharmaceuticals Inc., USA × 2 listings | ANDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Glenmark Pharmaceuticals Inc., USA × 4 listings | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 37.5 mg/g | Topical | Mayne Pharma | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Medimetriks Pharmaceuticals | ANDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Medimetriks Pharmaceuticals | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Northstar Rx LLC | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | NorthStar RxLLC | ANDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 25 mg/g | Topical | Oceanside Pharmaceuticals | NDA AUTHORIZED GENERIC | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 37.5 mg/g | Topical | Oceanside Pharmaceuticals | NDA AUTHORIZED GENERIC | View NDC → |
| 37.5; 10 mg/g; mg/g | Topical | Oceanside Pharmaceuticals | NDA AUTHORIZED GENERIC | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Oceanside Pharmaceuticals | NDA | Find on DailyMed ↗ |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 37.5 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| BENZOYL PEROXIDE 25 mg/g; CLINDAMYCIN PHOSPHATE 10 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| 25; 10 mg/g; mg/g | Topical | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Remedyrepack Inc. | ANDA | View NDC → |
| 50; 12 mg/g; mg/g | Topical | Sandoz Inc. | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 25 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | ANDA | View NDC → |
| 25; 10 mg/g; mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. × 3 listings | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Zydus Lifesciences Limited | ANDA | View NDC → |
| 50; 10 mg/g; mg/g | Topical | Zydus Lifesciences Limited | ANDA | View NDC → |
| CLINDAMYCIN PHOSPHATE 10 mg/g; BENZOYL PEROXIDE 50 mg/g | Topical | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Kits | ||||
| — | — | Bryant Ranch Prepack | ANDA | View NDC → |
| — | — | Encube Ethicals, Inc. | ANDA | View NDC → |
| — | Topical | Medimetriks Pharmaceuticals | ANDA | Find on DailyMed ↗ |
| — | — | Mylan Pharmaceuticals Inc. × 6 listings | ANDA | View NDC → |
| — | — | Padagis Israel Pharmaceuticals Ltd × 8 listings | ANDA | View NDC → |
| — | — | Sandoz Inc. | ANDA | View NDC → |
| — | Topical | Sandoz Inc. × 3 listings | ANDA | View NDC → |
| — | — | Sun Pharmaceutical Industries, Inc. × 4 listings | ANDA | View NDC → |
| — | — | Taro Pharmaceuticals U.S.A., Inc. × 4 listings | ANDA | View NDC → |
Showing 83 of 83 products — FDA National Drug Code Directory. See every product, package size and price: browse all 83 Clindamycin and Benzoyl Peroxide Topical NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Clindamycin and Benzoyl Peroxide Topical — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Clindamycin and Benzoyl Peroxide Topical in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Clindamycin and Benzoyl Peroxide Topical went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
📦 Supply & shortage status
Whether Clindamycin and Benzoyl Peroxide Topical is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Clindamycin and Benzoyl Peroxide Topical belongs to the Peroxides class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 33 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Oceanside Pharmaceuticals is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.